82 related articles for article (PubMed ID: 12399975)
1. Antiproliferative effects of a non-beta-oxidizable fatty acid, tetradecylthioacetic acid, in native human acute myelogenous leukemia blast cultures.
Tronstad KJ; Bruserud Ø; Berge K; Berge RK
Leukemia; 2002 Nov; 16(11):2292-301. PubMed ID: 12399975
[TBL] [Abstract][Full Text] [Related]
2. Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia.
Bruserud O; Tore Gjertsen B; Brustugun OT; Bassøe CF; Nesthus I; Espen Akselsen P; Bühring HJ; Pawelec G
Leukemia; 1995 Nov; 9(11):1910-20. PubMed ID: 7475283
[TBL] [Abstract][Full Text] [Related]
3. Growth reduction in glioma cells after treatment with tetradecylthioacetic acid: changes in fatty acid metabolism and oxidative status.
Tronstad KJ; Berge K; Dyroy E; Madsen L; Berge RK
Biochem Pharmacol; 2001 Mar; 61(6):639-49. PubMed ID: 11266648
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia: PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blasts.
Foss B; Ulvestad E; Bruserud Ø
Eur J Haematol; 2001 Oct; 67(4):267-78. PubMed ID: 11860452
[TBL] [Abstract][Full Text] [Related]
5. Leptin in human acute myelogenous leukemia: studies of in vivo levels and in vitro effects on native functional leukemia blasts.
Bruserud Ø; Huang TS; Glenjen N; Gjertsen BT; Foss B
Haematologica; 2002 Jun; 87(6):584-95. PubMed ID: 12031914
[TBL] [Abstract][Full Text] [Related]
6. Effects of interleukin-13 on cytokine secretion by human acute myelogenous leukemia blasts.
Bruserud O
Leukemia; 1996 Sep; 10(9):1497-1503. PubMed ID: 8751469
[TBL] [Abstract][Full Text] [Related]
7. Effects of gamma-irradiation on acute myelogenous leukemia blasts: in vitro studies of proliferation, constitutive cytokine secretion, and accessory cell function during T cell activation.
Bruserud O; Ulvestad E
J Hematother Stem Cell Res; 1999 Aug; 8(4):431-41. PubMed ID: 10634181
[TBL] [Abstract][Full Text] [Related]
8. Enhancement by transforming growth factor-beta 1 (TGF-beta 1) of the proliferation of leukemic blast progenitors stimulated with IL-3.
Suzuki T; Bessho M; Hirashima K; Tohda S; Nagata K; Morio T; Imai Y; Nara N
J Cell Physiol; 1991 Sep; 148(3):396-403. PubMed ID: 1717497
[TBL] [Abstract][Full Text] [Related]
9. Impact of mitochondrial beta-oxidation in fatty acid-mediated inhibition of glioma cell proliferation.
Berge K; Tronstad KJ; Bohov P; Madsen L; Berge RK
J Lipid Res; 2003 Jan; 44(1):118-27. PubMed ID: 12518030
[TBL] [Abstract][Full Text] [Related]
10. Flt3-mediated signaling in human acute myelogenous leukemia (AML) blasts: a functional characterization of Flt3-ligand effects in AML cell populations with and without genetic Flt3 abnormalities.
Bruserud Ø; Hovland R; Wergeland L; Huang TS; Gjertsen BT
Haematologica; 2003 Apr; 88(4):416-28. PubMed ID: 12681969
[TBL] [Abstract][Full Text] [Related]
11. Relations between IL-3-induced proliferation and in vitro cytokine secretion of bone marrow cells from AML patients.
Nowak R; Oelschlägel U; Gurth H; Range U; Albrecht S; Krebs U; Hietschold V; Ehninger G
Cytokine; 1999 Jun; 11(6):435-42. PubMed ID: 10346983
[TBL] [Abstract][Full Text] [Related]
12. Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemia.
Estrov Z; Estey EH; Andreeff M; Talpaz M; Kurzrock R; Reading CL; Deisseroth AB; Gutterman JU
Exp Hematol; 1992 Jun; 20(5):558-64. PubMed ID: 1587302
[TBL] [Abstract][Full Text] [Related]
13. Differentiation-inducing effect of recombinant human tumor necrosis factor alpha and gamma-interferon in vitro on blast cells from patients with acute myeloid leukemia and myeloid blast crisis of chronic myeloid leukemia.
Geissler K; Tricot G; Leemhuis T; Walker E; Broxmeyer HE
Cancer Res; 1989 Jun; 49(11):3057-62. PubMed ID: 2497971
[TBL] [Abstract][Full Text] [Related]
14. Effects of granulocyte-macrophage colony-stimulating factor and interleukin 6 on the growth of leukemic blasts in suspension culture.
Tsao CJ; Cheng TY; Chang SL; Su WJ; Tseng JY
Int J Cell Cloning; 1992 May; 10(3):166-72. PubMed ID: 1613267
[TBL] [Abstract][Full Text] [Related]
15. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
16. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
[TBL] [Abstract][Full Text] [Related]
17. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
[TBL] [Abstract][Full Text] [Related]
18. Lipoteichoic acid derived from Enterococcus faecalis modulates the functional characteristics of both normal peripheral blood leukocytes and native human acute myelogenous leukemia blasts.
Bruserud Ø; Wendelbo Ø; Paulsen K
Eur J Haematol; 2004 Nov; 73(5):340-50. PubMed ID: 15458513
[TBL] [Abstract][Full Text] [Related]
19. Effects of vascular endothelial growth factor on acute myelogenous leukemia blasts.
Foss B; Mentzoni L; Bruserud O
J Hematother Stem Cell Res; 2001 Feb; 10(1):81-93. PubMed ID: 11276362
[TBL] [Abstract][Full Text] [Related]
20. Antiinflammatory effects of tetradecylthioacetic acid involve both peroxisome proliferator-activated receptor alpha-dependent and -independent pathways.
Dyrøy E; Yndestad A; Ueland T; Halvorsen B; Damås JK; Aukrust P; Berge RK
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1364-9. PubMed ID: 15920037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]